University of Texas M D Anderson Cancer Center P2C — Houston, Texas

University of Texas M D Anderson Cancer Center P2C is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

University of Texas M D Anderson Cancer Center P2C has participated in 1 clinical trials.

Therapeutic areas: Metastatic Ureter Carcinoma, Metastatic Urethral Carcinoma, Stage III Bladder Urothelial Carcinoma AJCC v6 and v7.

Sponsors: National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Texas M D Anderson Cancer Center P2C?

University of Texas M D Anderson Cancer Center P2C has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Texas M D Anderson Cancer Center P2C conducted?

University of Texas M D Anderson Cancer Center P2C has 1 clinical trials on record. Their work covers Metastatic Ureter Carcinoma, Metastatic Urethral Carcinoma, Stage III Bladder Urothelial Carcinoma AJCC v6 and v7.

Is University of Texas M D Anderson Cancer Center P2C accredited by Crixeo Health?

University of Texas M D Anderson Cancer Center P2C has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Texas M D Anderson Cancer Center P2C?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.